Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22131Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Dimopoulos, C. | en |
| dc.contributor.author | Stokidis, D. | en |
| dc.contributor.author | Kallistratos, G. | en |
| dc.contributor.author | Sideris, C. | en |
| dc.contributor.author | Kyriakidis, A. | en |
| dc.contributor.author | Kollias, G. | en |
| dc.date.accessioned | 2015-11-24T19:21:55Z | - |
| dc.date.available | 2015-11-24T19:21:55Z | - |
| dc.identifier.issn | 0248-0018 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22131 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Amino Acids, Sulfur/therapeutic use | en |
| dc.subject | Cystinuria/drug therapy | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Kidney Calculi/drug therapy | en |
| dc.subject | Male | en |
| dc.subject | Recurrence | en |
| dc.subject | Tiopronin/therapeutic use | en |
| dc.subject | Urinary Calculi/drug therapy | en |
| dc.title | The use of mercapto-propionyl-glycine in the treatment of cystine lithiasis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/7276604 | - |
| heal.language | fr | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1981 | - |
| heal.abstract | The authors report the first results of the use of mercaptopropionyl-glycine (M.P.G.) in the solubilising and preventive treatment of cystine lithiasis. This substance results in the formation of a soluble cystine M.P.G. complex. It increases the solubility of cystine much more than D-penicillinamine. Twenty one cases of cystinuric cystine lithiasis were treated in this way, combined with forced diuresis, alkalinisation of the urine and uricolytic treatment. In 4 of their 21 patients, calculi disappeared completely, whilst in another 3 they decreased in size. Recurrence of lithiasis was avoided in 20 patients out of 21. These impressive results are similar to those in the brief literature concerned with the substance. Toxicity is virtually nil and its efficacy make this the drug par excellence for cystine lithiasis. | en |
| heal.journalName | J Urol (Paris) | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
